Skip to main content
AB

Austin Biosciences Corp.

Austin Biosciences develops novel drug delivery systems that enhance the therapeutic index of potent molecules. Their technology aims to improve drug efficacy and reduce side effects by optimizing how active pharmaceutical ingredients are delivered within the body.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Many potent drug molecules have limited therapeutic efficacy due to poor bioavailability, rapid degradation, off-target effects, and inability to reach the intended site of action within the body. These limitations often necessitate high doses, leading to increased systemic toxicity and reduced patient compliance.

Solution

Austin Biosciences develops advanced drug delivery systems designed to improve the pharmacokinetic and pharmacodynamic properties of therapeutic molecules. Their technology focuses on encapsulating drugs within biocompatible carriers that protect them from degradation, enhance their absorption and distribution, and enable targeted delivery to specific tissues or cells. By optimizing drug delivery, Austin Biosciences aims to increase drug efficacy, reduce side effects, and improve patient outcomes.

Target Audience

Pharmaceutical companies and research institutions seeking to improve the delivery and efficacy of their drug candidates.

Features

  • Proprietary encapsulation technology for controlled release of active pharmaceutical ingredients
  • Customizable carrier systems to optimize drug targeting and bioavailability
  • Enhanced drug stability and protection against enzymatic degradation
  • Reduced off-target effects and systemic toxicity
This profile is AI-generated and may contain inaccuracies.